Antiandrogen With Salvage RT Can Prolong Survival in Prostate Cancer

A long-term study found that adding 24 months of antiandrogen therapy with bicalutamide to salvage radiation therapy increased overall survival and prostate cancer –specific survival compared with placebo in men who underwent radical prostatectomy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Genitourinary Cancers News Prostate Cancer Source Type: news